Drug Shortage Report for JAMP TELMISARTAN
| Report ID | 169449 |
| Drug Identification Number | 02386755 |
| Brand name | JAMP TELMISARTAN |
| Common or Proper name | Telmisartan Tablets USP |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | TELMISARTAN |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 (blister) |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2022-10-13 |
| Actual start date | |
| Estimated end date | 2022-11-10 |
| Actual end date | 2022-10-21 |
| Shortage status | Resolved |
| Updated date | 2022-10-24 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2022-10-24 | French | Compare |
| v6 | 2022-10-24 | English | Compare |
| v5 | 2022-10-14 | English | Compare |
| v4 | 2022-10-07 | French | Compare |
| v3 | 2022-10-07 | English | Compare |
| v2 | 2022-09-16 | French | Compare |
| v1 | 2022-09-16 | English | Compare |
Showing 1 to 7 of 7